stockrow
Friday 6 November 2026
Export CON’s income statement to Excel — free account
Concentra Group Holdings Parent, Inc.
CON Healthcare Medical Care Facilities
Concentra Group Holdings Parent, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 13.9% from fiscal 2024.
- Revenue
- +8.61%
- EPS
- +36.8%
- Free cash flow
- −19.8%
- Total debt
- −5.65%
Quarter to September 2026, against a year earlier
42.16
1.40
−3.21%
Follow CON
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
20.37 | 19.19 | 15.43 | 15.14 |
+8 more quarters Free account |
P/S ratio |
1.84 | 1.63 | 1.21 | 1.17 | |
P/FCF ratio |
16.45 | 13.80 | 12.74 | 12.76 | |
P/Operating CF |
83.02 | 27.53 | 128.36 | 21.27 | |
P/B ratio |
8.37 | 7.68 | 6.24 | 6.30 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.46 | 2.25 | 1.89 | 1.86 | |
EV/EBITDA |
11.97 | 11.20 | 9.75 | 9.71 | |
EV/Operating CF |
17.57 | 15.31 | 14.59 | 14.39 | |
EV/FCF |
21.94 | 19.05 | 19.89 | 20.32 | |
Quick Ratio |
1.15 | 1.24 | 1.12 | 1.00 | |
Current Ratio |
1.30 | 1.38 | 1.26 | 1.14 | |
Net Debt/EBITDA |
10.52 | 10.41 | 13.02 | 16.43 | |
Debt/Assets |
50.51% | 52.28% | 54.54% | 55.08% | |
Debt/Equity |
2.96 | 3.25 | 3.65 | 3.93 | |
Asset Turnover |
0.80 | 0.78 | 0.79 | 0.80 | |
Operating CF/Net income |
0.79 | 2.07 | 0.42 | 3.37 | |
Capex/Depreciation |
(0.93) | (0.68) | (0.54) | (0.95) | |
Interest Coverage |
— | — | 3.68 | 1.27 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.79% | 9.35% | 9.71% | 9.42% | |
Intangible Assets out of Total Assets |
0.00 | 0.57 | 0.59 | 0.60 | |
Share Based Compensation of Revenue |
0.73% | 0.68% | 0.73% | 0.67% | |
Graham Net Nets |
(0.47) | (0.54) | (0.76) | (0.82) | |
Graham Number |
0.00 | 11.62 | 10.37 | 9.56 | |
Earnings Yield |
4.91% | 5.21% | 6.48% | 6.61% | |
Free Cash Flow Yield |
6.08% | 7.25% | 7.85% | 7.84% | |
Revenue per Share |
0.00 | 4.84 | 4.53 | 4.20 | |
Operating CF per Share |
0.00 | 1.08 | 0.17 | 0.93 | |
Capex per Share |
0.00 | (0.11) | (0.09) | (0.16) | |
Free Cash Flow per Share |
0.00 | 0.97 | 0.08 | 0.77 | |
Cash per Share |
0.00 | 1.26 | 0.49 | 0.62 | |
Shareholders Equity per Share |
0.00 | 3.87 | 3.44 | 3.13 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 3.87 | 3.44 | 3.13 | |
Free Cash Flow |
32.23 | 121.01 | 9.93 | 98.56 | |
Working Capital |
106.68 | 138.54 | 83.34 | 45.85 | |
Capital Expenditures |
(19.64) | (14.20) | (11.09) | (20.13) | |
Net Current Asset Value |
(2,037.23) | (2,019.07) | (2,053.34) | (2,074.26) | |
EV/EBIT |
14.52 | 13.71 | 12.06 | 12.03 | |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.04 | |
Price to Operating Income |
10.89 | 9.93 | 7.72 | 7.56 | |
| Other line items | |||||
Average Receivables |
299.62 | 285.79 | 277.32 | 237.81 | |
Average Payables |
33.67 | 37.65 | 33.46 | 20.38 | |
Average Assets |
2,927.78 | 2,925.93 | 2,809.50 | 2,689.78 | |
Average Common Equity |
452.71 | 416.27 | 372.33 | 340.87 |
Columns are period end dates · fundamentals updated 5 Nov 2026